Maibritt B. Andersen

542 total citations
19 papers, 447 citations indexed

About

Maibritt B. Andersen is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cognitive Neuroscience. According to data from OpenAlex, Maibritt B. Andersen has authored 19 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 4 papers in Cognitive Neuroscience. Recurrent topics in Maibritt B. Andersen's work include Neuroscience and Neuropharmacology Research (8 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Receptor Mechanisms and Signaling (5 papers). Maibritt B. Andersen is often cited by papers focused on Neuroscience and Neuropharmacology Research (8 papers), Neurotransmitter Receptor Influence on Behavior (8 papers) and Receptor Mechanisms and Signaling (5 papers). Maibritt B. Andersen collaborates with scholars based in Denmark, Norway and United States. Maibritt B. Andersen's co-authors include Thomas Werge, Frank Sams‐Dodd, Jens Zimmer, Jes Gerlach, Linda Peacock, Kjell Fuxé, Anders Fink‐Jensen, Åse Marie Hansen, Søren Peter Lund and Karin Sørig ­Hougaard and has published in prestigious journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and Neuropsychopharmacology.

In The Last Decade

Maibritt B. Andersen

19 papers receiving 434 citations

Peers

Maibritt B. Andersen
Maibritt B. Andersen
Citations per year, relative to Maibritt B. Andersen Maibritt B. Andersen (= 1×) peers Nana Hareyama

Countries citing papers authored by Maibritt B. Andersen

Since Specialization
Citations

This map shows the geographic impact of Maibritt B. Andersen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maibritt B. Andersen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maibritt B. Andersen more than expected).

Fields of papers citing papers by Maibritt B. Andersen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maibritt B. Andersen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maibritt B. Andersen. The network helps show where Maibritt B. Andersen may publish in the future.

Co-authorship network of co-authors of Maibritt B. Andersen

This figure shows the co-authorship network connecting the top 25 collaborators of Maibritt B. Andersen. A scholar is included among the top collaborators of Maibritt B. Andersen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maibritt B. Andersen. Maibritt B. Andersen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Andersen, Maibritt B., Carrie H. Croy, Ditte Dencker, et al.. (2015). Antipsychotic-Like Effect of the Muscarinic Acetylcholine Receptor Agonist BuTAC in Non-Human Primates. PLoS ONE. 10(4). e0122722–e0122722. 2 indexed citations
2.
Fogh, Karsten, Maibritt B. Andersen, Markus Zutt, et al.. (2012). Clinically relevant pain relief with an ibuprofen‐releasing foam dressing: Results from a randomized, controlled, double‐blind clinical trial in exuding, painful venous leg ulcers. Wound Repair and Regeneration. 20(6). 815–821. 24 indexed citations
3.
Madsen, Morten V., Linda Peacock, Thomas Werge, Maibritt B. Andersen, & Jesper T. Andreasen. (2010). Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys. Neuropharmacology. 60(2-3). 418–422. 3 indexed citations
4.
Andersen, Maibritt B., Thomas Werge, & Anders Fink‐Jensen. (2007). The Acetylcholinesterase Inhibitor Galantamine Inhibits d-Amphetamine-Induced Psychotic-Like Behavior in Cebus Monkeys. Journal of Pharmacology and Experimental Therapeutics. 321(3). 1179–1182. 15 indexed citations
5.
Madsen, Morten V., Linda Peacock, Thomas Werge, & Maibritt B. Andersen. (2006). Effects of the cannabinoid CB1 receptor agonist CP55,940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebusmonkeys. Journal of Psychopharmacology. 20(5). 622–628. 17 indexed citations
6.
­Hougaard, Karin Sørig, et al.. (2005). Prenatal stress may increase vulnerability to life events: Comparison with the effects of prenatal dexamethasone. Developmental Brain Research. 159(1). 55–63. 47 indexed citations
7.
Brandt‐Christensen, Mette, Maibritt B. Andersen, Anders Fink‐Jensen, Thomas Werge, & Jes Gerlach. (2005). The substituted (S)-3-phenylpiperidine (−)-OSU6162 reduces apomorphine- and amphetamine-induced behaviour in Cebus apella monkeys. Journal of Neural Transmission. 113(1). 11–19. 9 indexed citations
8.
Malík, Peter, Maibritt B. Andersen, & Linda Peacock. (2004). The effects of dopamine D3 agonists and antagonists in a nonhuman primate model of tardive dyskinesia. Pharmacology Biochemistry and Behavior. 78(4). 805–810. 14 indexed citations
9.
Sandager‐Nielsen, Karin, Maibritt B. Andersen, Thomas N. Sager, Thomas Werge, & Jørgen Scheel‐Krüger. (2004). Effects of postnatal anoxia on striatal dopamine metabolism and prepulse inhibition in rats. Pharmacology Biochemistry and Behavior. 77(4). 767–774. 10 indexed citations
10.
­Hougaard, Karin Sørig, Maibritt B. Andersen, Åse Marie Hansen, et al.. (2004). Effects of prenatal exposure to chronic mild stress and toluene in rats. Neurotoxicology and Teratology. 27(1). 153–167. 43 indexed citations
12.
Andersen, Maibritt B., Anders Fink‐Jensen, Linda Peacock, et al.. (2003). The Muscarinic M1/M4 Receptor Agonist Xanomeline Exhibits Antipsychotic-Like Activity in Cebus apella Monkeys. Neuropsychopharmacology. 28(6). 1168–1175. 71 indexed citations
13.
Andersen, Maibritt B., Kjell Fuxé, Thomas Werge, & Jes Gerlach. (2002). The adenosine A2A receptor agonist CGS 21680 exhibits antipsychotic-like activity in Cebus apella monkeys.. PubMed. 13(8). 639–44. 35 indexed citations
14.
Andersen, Maibritt B., Kjell Fuxé, Thomas Werge, & Jes Gerlach. (2002). The adenosine A2A receptor agonist CGS 21680 exhibits antipsychotic-like activity in Cebus apella monkeys. Behavioural Pharmacology. 13(8). 636–644. 31 indexed citations
15.
Andersen, Maibritt B., Jens Zimmer, & Frank Sams‐Dodd. (1999). Specific Behavioral Effects Related to Age and Cerebral Ischemia in Rats. Pharmacology Biochemistry and Behavior. 62(4). 673–682. 33 indexed citations
16.
Andersen, Maibritt B. & Frank Sams‐Dodd. (1998). Impairment of working memory in the T-maze after transient global cerebral ischemia in the Mongolian gerbil. Behavioural Brain Research. 91(1-2). 15–22. 14 indexed citations
17.
Andersen, Maibritt B., Jens Zimmer, & Frank Sams‐Dodd. (1997). Postischemic hyperactivity in the Mongolian gerbil correlates with loss of hippocampal neurons.. Behavioral Neuroscience. 111(6). 1205–1216. 33 indexed citations
18.
Andersen, Maibritt B. & Frank Sams‐Dodd. (1997). Transient Cerebral Ischemia Inhibits Juvenile Recognition in the Mongolian Gerbil. Pharmacology Biochemistry and Behavior. 56(4). 719–725. 7 indexed citations
19.
Andersen, Maibritt B., Jens Zimmer, & Frank Sams‐Dodd. (1997). Postischemic hyperactivity in the Mongolian gerbil correlates with loss of hippocampal neurons.. Behavioral Neuroscience. 111(6). 1205–1216. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026